Supramolecular Attack Particles (SMAPs) – Nanoparticles from killer T cells engineered for immunotherapeutic use
![Image from Licence Details: Supramolecular Attack Particles (SMAPs) – Nanoparticles from killer T cells engineered for immunotherapeutic use](https://innovation.ox.ac.uk/wp-content/uploads/2023/10/16954-image-300x130.jpg)
Applications: Therapeutics, oncology, immunotherapy
SMAPs are particles released from cytotoxic T lymphocytes (CTLs) that autonomously kill target cells. They can be engineered to deliver cargoes and functionalised to target specific organs or cells.
Features | Benefits |
|
|
|
|
|
|
|
|
|
|
about this technology
© Oxford University Innovation